WO2009081369A3 - Method for treating fetal growth disorders - Google Patents

Method for treating fetal growth disorders Download PDF

Info

Publication number
WO2009081369A3
WO2009081369A3 PCT/IB2008/055461 IB2008055461W WO2009081369A3 WO 2009081369 A3 WO2009081369 A3 WO 2009081369A3 IB 2008055461 W IB2008055461 W IB 2008055461W WO 2009081369 A3 WO2009081369 A3 WO 2009081369A3
Authority
WO
WIPO (PCT)
Prior art keywords
fetal growth
growth disorders
treating fetal
treating
disorders
Prior art date
Application number
PCT/IB2008/055461
Other languages
French (fr)
Other versions
WO2009081369A2 (en
Inventor
Charles Chany
Ammar Achour
Jean-Pierre Mbika Binzangi
Original Assignee
Association Pour Le Développement De La Biothérapie Expérimentale Et Appliquée (Adbea)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Association Pour Le Développement De La Biothérapie Expérimentale Et Appliquée (Adbea) filed Critical Association Pour Le Développement De La Biothérapie Expérimentale Et Appliquée (Adbea)
Publication of WO2009081369A2 publication Critical patent/WO2009081369A2/en
Publication of WO2009081369A3 publication Critical patent/WO2009081369A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1732—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention relates to a method for treating fetal growth disorders comprising in utero administering to a fetus in need thereof a therapeutical efficient amount of sarcolectine (SCL in short) having SEQ ID N°1 and/or biologically active fragments thereof.
PCT/IB2008/055461 2007-12-20 2008-12-19 Method for treating fetal growth disorders WO2009081369A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1531107P 2007-12-20 2007-12-20
US61/015,311 2007-12-20

Publications (2)

Publication Number Publication Date
WO2009081369A2 WO2009081369A2 (en) 2009-07-02
WO2009081369A3 true WO2009081369A3 (en) 2009-11-12

Family

ID=40801636

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/055461 WO2009081369A2 (en) 2007-12-20 2008-12-19 Method for treating fetal growth disorders

Country Status (1)

Country Link
WO (1) WO2009081369A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020927A1 (en) * 1995-12-05 1997-06-12 Association Pour Le Developpement De La Biotherapie Experimentale Et Appliquee (A.D.B.E.A.) Compounds having lectin properties and biological uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020927A1 (en) * 1995-12-05 1997-06-12 Association Pour Le Developpement De La Biotherapie Experimentale Et Appliquee (A.D.B.E.A.) Compounds having lectin properties and biological uses thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHANY-FOURNIER F ET AL: "SARCOLECTIN AND INTERFERON IN THE REGULATION OF CELL GROWTH", JOURNAL OF CELLULAR PHYSIOLOGY, vol. 145, no. 1, 1990, pages 173 - 180, XP000579279, ISSN: 0021-9541 *
EBBESEN P ET AL: "Concurrence of high levels of interferons [alpha] and [beta] in cord and maternal blood and simultaneous presence of interferon in trophoblast in an African population", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 1995 US, vol. 15, no. 2, 1995, pages 123 - 128, XP002545484, ISSN: 1079-9907 *
FRENDO J L ET AL: "Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 85, no. 10, October 2000 (2000-10-01), pages 3700 - 3707, XP002545483, ISSN: 0021-972X *
KABA A ET AL: "Role of recombinant sarcolectin as an interferon antagonist in the regulation of cell growth", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, vol. 17, no. SUPPL. 2, October 1997 (1997-10-01), & ANNUAL MEETING OF THE INTERNATIONAL SOCIETY FOR INTERFERON AND CYTOKINE RESEARCH; SAN DIEGO, CALIFORNIA, USA; OCTOBER 19-24, 1997, pages S65, XP008111401, ISSN: 1079-9907 *
LOO CHRISTINE K C ET AL: "N-CAM and keratins 7 and 20 in the ductal plate malformation of the Meckel-Gruber syndrome.", PATHOLOGY AUG 2006, vol. 38, no. 4, August 2006 (2006-08-01), pages 374 - 376, XP008111403, ISSN: 0031-3025 *
RODRIGUEZ M D ET AL: "EVALUATION OF THE TOXICOLOGICAL EFFECTS OF RECOMBINANT HUMAN ALPHA-2B INTERFERON ON THE FERTILITY AND REPRODUCTION ON RATS EVALUATION OF THE TERATOGENIC CAPACITY IN-VITRO", BIOTECNOLOGIA APLICADA, vol. 7, no. 3, 1990, pages 276 - 281, XP008111810, ISSN: 0864-4551 *

Also Published As

Publication number Publication date
WO2009081369A2 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
EP2175834B8 (en) Glp-1-fc fusion protein formulation
CA2512229A1 (en) Clavicular bone plate
WO2012019168A3 (en) Engineered nucleic acids and methods of use thereof
WO2005094553A3 (en) Compositions for promoting bone growth and methods thereof
WO2011039502A3 (en) Surgical implant
WO2004037861A3 (en) Neutralizing antibodies against gdf-8 and uses therefor
WO2006133955A8 (en) Adamts13-comprising compositions having thrombolytic activity
WO2009079451A3 (en) Compositions and methods of promoting wound healing
NZ601868A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
WO2008017025A3 (en) Combination therapy
WO2008005465A3 (en) Tissue fasteners and related insertion devices, mechanisms, and methods
WO2001043732A3 (en) Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
WO2009020643A3 (en) Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue
WO2007100459A3 (en) Surgical slings
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
ZA200703166B (en) Composition comprising lactic acid and lactoferrin
WO2011075606A3 (en) Hyperglycosylated polypeptide variants and methods of use
EP2042184A4 (en) Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle
WO2006122327A3 (en) Milk fat globule epidermal growth factor-factor viii and sepsis
AU2003220115A8 (en) Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues
WO2006045314A3 (en) Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease
TW200716153A (en) Mitotic kinesin inhibitors and methods of use thereof
NZ591136A (en) A composition for treating aids and associated conditions comprising plant extracts
WO2001072685A3 (en) Polyamine analogues as cytotoxic agents

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08863681

Country of ref document: EP

Kind code of ref document: A2